Skip to content

Blocking the Phase Separation of hnRNP L Attenuates Pulmonary Fibrogenesis by Inhibiting Fibroblast-to-myofibroblast Differentiation.

Jul 2026 · Current Gene Therapy · Vol 26 · 0 citations
Medicine

TL;DR

The findings reveal that TGF-β1-enhanced phase separation of the chromatin-associated RBP hnRNP L promotes gene transcription and facilitates profibrotic phenotypes in lung myofibroblasts, suggesting a phase-separation-based therapeutic strategy.

Abstract

INTRODUCTION Pulmonary fibrosis is an interstitial lung disease characterized by diverse etiologies and unknown mechanisms. Phase separation has been implicated in the development of numerous diseases, but its role in the pathogenesis of pulmonary fibrogenesis remains unclear. In this study, we explored whether heterogeneous nuclear ribonucleoprotein L (hnRNP L) can form phase-separation condensates that contribute to the progression of pulmonary fibrosis.

Methods

Pulmonary fibrosis was modeled in vitro using TGF-β1-treated fibroblasts and in vivo by intratracheal bleomycin administration in mice. Phase-separation formation was evaluated by droplet formation and fluorescence recovery after photobleaching experiments. Adeno-associated virus vectors overexpressing full-length hnRNP L or hnRNP L-Δ26-111 & 274-374 (truncation of amino acid fragments 26-111 and 274-374) were constructed and delivered into murine lungs using a Penn-Century MicroSprayer device. Micro-computed tomography imaging, forced vital capacity tests, hematoxylin and eosin staining, and Masson's trichrome staining were performed to assess the anti-fibrotic effect of disrupting hnRNP L phase separation. RNA-seq was employed to explore the underlying molecular targets of hnRNP L.

Results

In vivo and in vitro results revealed that the role of hnRNP L in promoting fibroblast differentiation depended on its phase separation, and the amino acid fragments 26-111 and 274-374 were essential to this process. Phenotypic, physiological, and histological analyses demonstrated that hnRNP L overexpression accelerated the development of pulmonary fibrogenesis. In contrast, truncated hnRNP L-Δ26-111 and 274-374 improved lung tissue structure and function and reduced collagen deposition by blocking hnRNP L phase separation. RNA-seq results showed that a total of 1,155 dysregulated genes (FDR < 0.05, |logFC| > 1) were detected after silencing hnRNP L using small interfering RNA (siRNA) in TGF-β1-treated MRC-5 cells. Most differentially expressed genes were related to lung fibrosis, including TGFBR1, CXCL8, WWTR1, FAP, VIM, α-SMA, and collagen. The RNA levels of these genes were evidently regulated by silencing or overexpressing hnRNP L. Notably, we observed that hnRNP L phase separation promoted histone modifications such as H3K27ac, H4K8la, H4K12la, and H4K16la, which are associated with active chromatin.

Discussion

Our findings reveal that TGF-β1-enhanced phase separation of the chromatin-associated RBP hnRNP L promotes gene transcription and facilitates profibrotic phenotypes in lung myofibroblasts, suggesting a phase-separation-based therapeutic strategy.

Conclusion

Blocking hnRNP L phase separation inhibited fibroblast-to-myofibroblast differentiation, attenuating pulmonary fibrogenesis. This study reveals a novel regulatory mechanism by which phase separation contributes to the development of pulmonary fibrosis.

View source

Similar papers

Open access Aug 2026

Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression.

BACKGROUND Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease driven by aberrant extracellular matrix deposition, with the activity of transforming growth factor-beta 1 (TGF-β1) orchestrating fibrogenesis. Current therapies are limited by severe adverse effects, highlighting the unmet need f...

Juan Manuel Velázquez-Enríquez, Alma Aurora Ramírez-Hernández, Jovito Cesar Santos-Álvarez et al. · 0 citations
Open access Aug 2026

Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.

It is suggested that MAGI2 acts as a negative regulator of myofibroblast differentiation by stabilizing PTEN, whereas PREX2 is aberrantly expressed in the fibrotic milieu, negatively modulating MAGI2, thereby accelerating pulmonary fibrosis.

Yozo Sato, K. Kamio, Yasuhiro Terasaki et al. · 0 citations
Aug 2026

Mannose-modified tobacco mosaic virus-mediated macrophage regulation inhibits pulmonary fibrosis progression.

Idiopathic pulmonary fibrosis (IPF) is a chronic disease, causing irreversible lung scarring and respiratory failure. CD206+ M2 macrophages play a key role in its progression. In this study, we utilize the pro-inflammatory properties of plant viruses to develop a mannose-modified tobacco mosaic virus nanoparticle (TMV-...

Jiaodan Jin, Ren Xu, H. Fu et al. · 0 citations
Open access Sep 2026

Dupilumab Alleviates Pulmonary Fibrosis by Interrupting Profibrotic Macrophage-Fibroblast Crosstalk and IL4R/JAK/STAT Signaling

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease (ILD) of unclear etiology. Dupilumab, a humanized monoclonal antibody binding to interleukin-4 receptor alpha (IL-4Rα), suppresses both IL-4 and IL-13 signaling pathways. However, the therapeutic potential in IPF is unclear. This re...

Qi Chen, Yu-Pei Zhang, Shi-Yang Wang et al. · 0 citations
Open access Aug 2026

MiRNA let-7a-5p Ameliorates Pulmonary Fibrosis by Suppressing TGFBR1-Mediated Endothelial-to-Mesenchymal Transition

Background Idiopathic Pulmonary Fibrosis (IPF) is a fatal chronic lung disease with limited therapeutic options. While alveolar epithelial injury and fibroblast activation are well-studied, endothelial-mesenchymal transition (EndoMT) is emerging as a critical pathogenic mechanism. The regulatory role of exosomal miRNAs...

J. Pang, Jia-Rui Shen, Wei Yang et al. · 0 citations
Open access Aug 2026

Formononetin ameliorates bleomycin-induced pulmonary fibrosis in mice via targeting USP5

Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with limited therapeutic options. Transforming growth factor beta 1 (TGF-β1) is a major profibrotic mediator that promotes fibroblast activation and extracellular matrix (ECM) deposition. This study aimed to evaluate t...

Yong-Ping Wang, Xue-Ze Liu, Hao Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.